EUVIMEDEUVIMED entdecken
Open Access

Pharmacological Activation of AMP-activated Protein Kinase Ameliorates Liver Fibrosis in a Metabolic Dysfunction-Associated Steatohepatitis Mouse Model

Seojeong Kim, Jae-Ho Shin, Minjung Seo, Eun Seon Pak, Kyung-Hwa Jeon, Inhye Moon, Jisoo Kang, Wonhyo Seo, Younghwa Na, Youngjoo Kwon

International Journal of Biological Sciences · 2025

DOI: 10.7150/ijbs.108731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Seojeong Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Liver Cirrhosis, Fatty Liver, Sulfonamides. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesLiver CirrhosisFatty LiverSulfonamidesAnimalsMiceHepatic Stellate CellsHumansMaleDisease Models, AnimalHepatocytesMice, Inbred C57BLReactive Oxygen SpeciesDiet, High-Fat

Stichwörter der Autor:innen

4-chloro-benzenesulfonamide derivativeAMP-activated protein kinase (AMPK)lipid accumulationliver fibrosismetabolic dysfunction-associated steatohepatitis (MASH)synthetic AMPK activator

Substanzen

AMP-Activated Protein KinasesReactive Oxygen SpeciesSulfonamides

Autor:innen und Institutionen

  • College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, 03760, Republic of Korea.
  • College of Pharmacy, CHA University, Pocheon, 487-010, Korea.
  • Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, 03760, Korea.

Zitieren

APA

Kim, S., Shin, J. H., Seo, M., Pak, E. S., Jeon, K. H., Moon, I., Kang, J., Seo, W., Na, Y., & Kwon, Y. (2025). Pharmacological Activation of AMP-activated Protein Kinase Ameliorates Liver Fibrosis in a Metabolic Dysfunction-Associated Steatohepatitis Mouse Model. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.108731

Vancouver

Kim S, Shin JH, Seo M, Pak ES, Jeon KH, Moon I, et al. Pharmacological Activation of AMP-activated Protein Kinase Ameliorates Liver Fibrosis in a Metabolic Dysfunction-Associated Steatohepatitis Mouse Model. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.108731

BibTeX
@article{Kim2025,
  author = {Kim, Seojeong and Shin, Jae-Ho and Seo, Minjung and Pak, Eun Seon and Jeon, Kyung-Hwa and Moon, Inhye and Kang, Jisoo and Seo, Wonhyo and Na, Younghwa and Kwon, Youngjoo},
  title = {Pharmacological Activation of AMP-activated Protein Kinase Ameliorates Liver Fibrosis in a Metabolic Dysfunction-Associated Steatohepatitis Mouse Model},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  doi = {10.7150/ijbs.108731}
}
Kostenlos starten →